From the Editor
From the Editor
Financial navigators saved about $2,500 per cancer patient
Partnering with financial navigators helped blood cancer patients sort through complex medical expenses and save money, a study showed.
From the Editor
Building (or rebuilding) trust amid vaccine hesitancy
From the Editor
Reporting for duty at the front lines of COVID-19: From your editor in chief
From the Editor
Welcome Editorial
From the Editor
Becoming the paradigm for clinical trial enrollment
From the Editor
Resignation
Ambition is overrated. The ambitious find it harder to accept failure, and some degree of failure is likely.
From the Editor
Treat or treat
When assessing whether to recommend treatment, it’s tough to know the difference between tricks and treats.
From the Editor
Clinical trials in sarcoma bring hope and promise
From the Editor
Reunion
Here we were, three accomplished physicians all resigning from powerful posts at the same time for what turns out to be similar reasons. Our...
From the Editor
Timed perfectly
His leukemia was asymptomatic, indolent, and required no treatment. He could have waited 6 months to be seen. But, no; he couldn’t.
From the Editor
Rat race
A rat race can be more than just a competitive quest for financial gain. In politics, the quest is more for power. In sports, the quest includes...